Patient characteristics
| Patient No. . | Sex . | Age (y) . | Diagnosis . | Disease Duration (y) . | Hb g/dL . | WBC ×109/L . | Neut ×109/L . | Platelet ×109/L . |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 36 | AA | 8 | 14.4 | 7.8 | 5.8 | 193 |
| 2 | F | 28 | NSAA | 5.9 | 13 | 3.2 | 7.3 | 49 |
| 3 | F | 71 | AA | 0.2 | NA | NA | NA | NA |
| 4 | F | 61 | NSAA | 2.3 | 8.3 | 7.8 | 5.9 | 279 |
| 5 | F | 26 | NSAA | <0.1 | 8.3 | 3.5 | 1.5 | 40 |
| 6 | F | 24 | AA | <0.1 | 6.3 | 2.3 | 0.9 | 19 |
| 7 | F | 33 | NSAA | 4 | 12.3 | 3 | 1.3 | 10 |
| 8 | F | 68 | NSAA | 0.5 | 11.3 | 5.9 | NA | 93 |
| 9 | F | 38 | NSAA | 3.6 | 11.4 | 6.5 | 3.7 | 107 |
| 10 | F | 64 | AA/MDS | 5.2 | 8.3 | 9.2 | 2.8 | 29 |
| 11 | F | 69 | AA/MDS | 7 | 8.4 | 1.1 | 0.1 | 6 |
| 12 | M | 71 | AA/MDS | 3.6 | 9.1 | 4.8 | 0.8 | 74 |
| 13 | F | 21 | AA/PNH | 2.5 | 10.6 | 5.6 | 3 | 127 |
| 14 | F | 29 | AA/PNH | 12 | 7.8 | 1.9 | 2.7 | 62 |
| 15 | F | 54 | AA/PNH | 13 | 10.3 | 6.9 | 3.9 | 22 |
| 16 | F | 35 | AA/PNH | 21 | 6.4 | 3.4 | — | 105 |
| 17 | F | 34 | AA/PNH | 12 | 10 | 4 | 2.9 | 137 |
| 18 | F | 60 | AA/PNH | 12 | 10.3 | 3.1 | 2.1 | 75 |
| 19 | M | 67 | AA/PNH | 1.9 | 7.9 | 1.0 | 0.1 | 47 |
| 20 | M | 43 | AA/PNH | 4.5 | 11.2 | 2.7 | 1.5 | 47 |
| 21 | M | 29 | AA/PNH | 6.5 | 13.5 | 4.5 | 2.7 | 106 |
| 22 | M | 31 | AA/PNH | 1.8 | 10.2 | 3.9 | 2.6 | 173 |
| 23 | M | 30 | AA/PNH | 10 | 11.9 | 3.1 | — | 64 |
| 24 | M | 30 | AA/PNH | 1.2 | 13.4 | 4.3 | — | 63 |
| 25 | M | 24 | AA/PNH | 1 | 13.5 | 3.4 | — | 159 |
| 26 | M | 51 | AA/PNH | 1.4 | 10.3 | 0.7 | 0.1 | 10 |
| 27 | M | 31 | AA/PNH | 0.1 | 10 | 4.9 | 2.8 | 62 |
| 28 | M | 55 | AA/PNH | 3 | 9 | 1.4 | 0.3 | 10 |
| 29 | M | 42 | AA/PNH | 24 | 9.9 | 3.2 | — | 36 |
| 30 | M | 41 | AA/PNH | 1.6 | 9 | 1.7 | 0.8 | 25 |
| Patient No. . | Sex . | Age (y) . | Diagnosis . | Disease Duration (y) . | Hb g/dL . | WBC ×109/L . | Neut ×109/L . | Platelet ×109/L . |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 36 | AA | 8 | 14.4 | 7.8 | 5.8 | 193 |
| 2 | F | 28 | NSAA | 5.9 | 13 | 3.2 | 7.3 | 49 |
| 3 | F | 71 | AA | 0.2 | NA | NA | NA | NA |
| 4 | F | 61 | NSAA | 2.3 | 8.3 | 7.8 | 5.9 | 279 |
| 5 | F | 26 | NSAA | <0.1 | 8.3 | 3.5 | 1.5 | 40 |
| 6 | F | 24 | AA | <0.1 | 6.3 | 2.3 | 0.9 | 19 |
| 7 | F | 33 | NSAA | 4 | 12.3 | 3 | 1.3 | 10 |
| 8 | F | 68 | NSAA | 0.5 | 11.3 | 5.9 | NA | 93 |
| 9 | F | 38 | NSAA | 3.6 | 11.4 | 6.5 | 3.7 | 107 |
| 10 | F | 64 | AA/MDS | 5.2 | 8.3 | 9.2 | 2.8 | 29 |
| 11 | F | 69 | AA/MDS | 7 | 8.4 | 1.1 | 0.1 | 6 |
| 12 | M | 71 | AA/MDS | 3.6 | 9.1 | 4.8 | 0.8 | 74 |
| 13 | F | 21 | AA/PNH | 2.5 | 10.6 | 5.6 | 3 | 127 |
| 14 | F | 29 | AA/PNH | 12 | 7.8 | 1.9 | 2.7 | 62 |
| 15 | F | 54 | AA/PNH | 13 | 10.3 | 6.9 | 3.9 | 22 |
| 16 | F | 35 | AA/PNH | 21 | 6.4 | 3.4 | — | 105 |
| 17 | F | 34 | AA/PNH | 12 | 10 | 4 | 2.9 | 137 |
| 18 | F | 60 | AA/PNH | 12 | 10.3 | 3.1 | 2.1 | 75 |
| 19 | M | 67 | AA/PNH | 1.9 | 7.9 | 1.0 | 0.1 | 47 |
| 20 | M | 43 | AA/PNH | 4.5 | 11.2 | 2.7 | 1.5 | 47 |
| 21 | M | 29 | AA/PNH | 6.5 | 13.5 | 4.5 | 2.7 | 106 |
| 22 | M | 31 | AA/PNH | 1.8 | 10.2 | 3.9 | 2.6 | 173 |
| 23 | M | 30 | AA/PNH | 10 | 11.9 | 3.1 | — | 64 |
| 24 | M | 30 | AA/PNH | 1.2 | 13.4 | 4.3 | — | 63 |
| 25 | M | 24 | AA/PNH | 1 | 13.5 | 3.4 | — | 159 |
| 26 | M | 51 | AA/PNH | 1.4 | 10.3 | 0.7 | 0.1 | 10 |
| 27 | M | 31 | AA/PNH | 0.1 | 10 | 4.9 | 2.8 | 62 |
| 28 | M | 55 | AA/PNH | 3 | 9 | 1.4 | 0.3 | 10 |
| 29 | M | 42 | AA/PNH | 24 | 9.9 | 3.2 | — | 36 |
| 30 | M | 41 | AA/PNH | 1.6 | 9 | 1.7 | 0.8 | 25 |
F, female; Hb, hemoglobin; M, male; NA, not available; Neut, neutrophil; WBC, white blood count.
A case report on patient 12 has been published.12